Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

It was really about the O2 sensor patent infringement case Masimo brought against Apple. In theory, that’s a completely unrelated case. In practice, not so much. If you need a quick recap ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

As always, the man from Masimo has strong words. Apple has replied. The firm claims that the blood oxygen sensor is accurate, and that, in essence, Kiani isn’t telling the truth. The difference ...

New features like the Tides App on the Watch Ultra 2 probably don't get as the still-missing pulse oximetry sensing. © Photo: Florence Ion / Gizmodo For most regular ...

Kiani has been in it since starting Masimo in 1989. Along with being chairman and CEO, he holds more than 500 patents or ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Masimo Corporation (NASDAQ:MASI) is a global medical technology company specializing in noninvasive patient monitoring technologies. It develops and manufactures monitoring devices, sensors ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...